Luxium Solutions

Founded in 1979, Ballard Power Systems Inc. provides clean energy fuel cell products, enabling optimized power systems for a range of applications. Based in Lowell, Mass., it caters to different sectors, including aerospace, automotive, electrical, fuel cell and sports equipment industries. The company manufactures a wide range of fuel cell products for motive power and stationary power applications. It is recognized as one of the leaders in the development, manufacture, sale and servicing of clean energy hydrogen fuel cells. Jantzi-Maclean's Corporate Responsibility Report named Ballard Power Systems Inc. as one of the 50 most socially responsible companies in Canada.

MAKScientific is a Boston-based pharmaceutical company that is dedicated to developing drugs targeting the endocannabinoid system to treat various medical disorders. With a focus on selective targeting of components such as cannabinoid receptors and enzymes, they have a growing portfolio of small molecule modulators that have shown promise in animal models of human disease. One of their advanced drug candidates, AM6545, is a peripherally restricted CB1 receptor antagonist that offers a potential new approach to managing chronic liver disease and metabolic disorders. Seeking a partner for further development and commercialization, MAKScientific has already advanced this drug candidate to the late pre-clinical stage with no adverse pre-clinical data to date.Generated from the website

Glycosyn LLC is a biotechnology company based in Woburn, MA, focused on developing products derived from unique bioactive sugars found in human milk, known as Human Milk Oligosaccharides (HMOs). The company's mission is to enhance infant and child health by combating infectious and chronic diseases globally through the application of these natural sugars in nutrition, therapeutics, and diagnostics. With a commitment to promoting normal gut ecology and enhancing immune function, Glycosyn's products aim to positively impact overall intestinal health and address serious conditions such as infectious diarrhea, childhood respiratory diseases, inflammatory bowel disease, irritable bowel syndrome, and metabolic diseases. Recent advances in glycobiology have unveiled the potential of these natural food products in human nutrition and disease prevention and treatment. Generated from the website